Finally, since microenvironmental effects, such as expression of interleukin (IL)-6, may modulate the expression of p53 [43], we evaluated the activity of MI-63 on myeloma cells in the presence of HS-5 human stromal cells. The gene discussed is IL6; the disease is plasma cell myeloma.